Troglitazone reduces plasma levels of tumour necrosis factor-α in obese patients with type 2 diabetes

被引:36
作者
Katsuki, A [1 ]
Sumida, Y [1 ]
Murata, K [1 ]
Furuta, M [1 ]
Araki-Sasaki, R [1 ]
Tsuchihashi, K [1 ]
Hori, Y [1 ]
Yano, Y [1 ]
Gabazza, EC [1 ]
Adachi, Y [1 ]
机构
[1] Mie Univ, Sch Med, Dept Internal Med 3, Tsu, Mie 5148507, Japan
关键词
troglitazone; tumour necrosis factor-alpha; obesity; type; 2; diabetes;
D O I
10.1046/j.1463-1326.2000.00072.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the effect of troglitazone (given orally 400 mg/day) on glucose intolerance and on the plasma levels of tumour necrosis factor-alpha (TNF-alpha) in 12 obese patients with type 2 diabetes for 12 weeks. Troglitazone significantly decreased fasting plasma glucose, serum C-peptide, serum insulin and HbA(1c) levels. Plasma levels of TNF-alpha were significantly reduced by troglitazone administered for 8 and 12 weeks. Troglitazone administration significantly improved insulin resistance, but did not affect pancreatic beta-cell function as evaluated by the homeostasis model assessment (HOMA). In the present study, we reported for the first time that troglitazone administration significantly reduces plasma levels of TNF-alpha in obese patients with type 2 diabetes.
引用
收藏
页码:189 / 191
页数:3
相关论文
共 12 条
[1]   Tumor necrosis factor-α in sera of obese patients:: Fall with weight loss [J].
Dandona, P ;
Weinstock, R ;
Thusu, K ;
Abdel-Rahman, E ;
Aljada, A ;
Wadden, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2907-2910
[2]   Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus [J].
Katsuki, A ;
Sumida, Y ;
Murashima, S ;
Murata, K ;
Takarada, Y ;
Ito, K ;
Fujii, M ;
Tsuchihashi, K ;
Goto, H ;
Nakatani, K ;
Yano, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :859-862
[3]   Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes [J].
Kirchgessner, TG ;
Uysal, K ;
Wiesbrock, SM ;
Marino, MW ;
Hotamisligil, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2777-2782
[4]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[5]   TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone [J].
Miles, PDG ;
Romeo, OM ;
Higo, K ;
Cohen, A ;
Rafaat, K ;
Olefsky, JM .
DIABETES, 1997, 46 (11) :1678-1683
[6]   Effect of troglitazone on body fat distribution in type 2 diabetic patients [J].
Mori, Y ;
Murakawa, Y ;
Okada, K ;
Horikoshi, H ;
Yokoyama, J ;
Tajima, N ;
Ikeda, Y .
DIABETES CARE, 1999, 22 (06) :908-912
[7]   Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats [J].
Okuno, A ;
Tamemoto, H ;
Tobe, K ;
Ueki, K ;
Mori, Y ;
Iwamoto, K ;
Umesono, K ;
Akanuma, Y ;
Fujiwara, T ;
Horikoshi, H ;
Yazaki, Y ;
Kadowaki, T .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1354-1361
[8]   Advancing age and insulin resistance:: role of plasma tumor necrosis factor-α [J].
Paolisso, G ;
Rizzo, MR ;
Mazziotti, G ;
Tagliamonte, MR ;
Gambardella, A ;
Rotondi, M ;
Carella, C ;
Giugliano, D ;
Varricchio, M ;
D'Onofrio, F .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 275 (02) :E294-E299
[9]   Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling [J].
Peraldi, P ;
Xu, M ;
Spiegelman, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) :1863-1869
[10]   Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus [J].
Pfeiffer, A ;
Janott, J ;
Mohlig, M ;
Ristow, M ;
Rochlitz, H ;
Busch, K ;
Schatz, H ;
Schifferdecker, E .
HORMONE AND METABOLIC RESEARCH, 1997, 29 (03) :111-114